PDF - 4.73MB - Australian Sports Anti-Doping Authority

More documents

Recommendations

Info

OVERVIEWThe Australian Sports Drug Medical Advisory Committee (ASDMAC) was established under section 52 of the AustralianSports Anti-Doping Authority Act 2006 (the ASADA Act) and clause 5 of the National Anti-Doping (NAD) scheme.ASDMAC performs its functions in accordance with the World Anti-Doping Code (the Code), the InternationalStandard for Therapeutic Use Exemptions (TUEs), the ASADA Act and the NAD scheme.During the year, Dr Hugh Hazard, an inaugural member of ASDMAC retired and Dr Terry Farquharson left theCommittee. Their replacements were Dr Carolyn Broderick and Dr Andrew Potter.ASDMAC held four meetings and processed 337 TUE applications in 2012–13.FUNCTIONSClause 5.01 NAD scheme — functions of ASDMACUnder the NAD scheme, ASDMAC’s functions are as follows:> ASDMAC may give an athlete approval, in accordance with the Code and the International Standard for TUEs,to use a prohibited substance or a prohibited method for therapeutic purposes.> ASDMAC may develop and implement its own procedure for the issuing of TUEs in accordance with theInternational Standard for TUEs.> If an athlete has an approval for the use of a prohibited substance or a prohibited method for therapeuticpurposes, ASDMAC may investigate the sample analysis result for a sample given by the athlete to find outwhether the athlete has complied with the conditions of the approval.> ASDMAC may investigate an atypical finding or an adverse analytical finding for a sample given by an athlete tofind out whether the atypical finding or adverse analytical finding was caused by naturally occurring levels of thesubstance concerned.> ASDMAC may review the procedures adopted by a sporting administration body for approving the use of aprohibited substance or a prohibited method.> ASDMAC may provide advice relating to TUEs and ASDMAC functions to ASADA, sporting administrationbodies, participants or other TUE committees.> If ASADA consults with ASDMAC about whether an approval for the use of a prohibited substance or aprohibited method for therapeutic purposes was given:• by ASDMAC, or• by a TUE committee, or• because of a decision by the World Anti-Doping Agency (WADA) following a review or appeal, ASDMAC mayinvestigate the approval and give its opinion to ASADA.> ASDMAC may participate in a review or an appeal that is related directly or indirectly to a decision made byASDMAC to:• approve the use of a prohibited substance or a prohibited method for therapeutic purposes, or• refuse to approve the use of a prohibited substance or a prohibited method for therapeutic purposes.138
Australian Sports Drug Medical Advisory Committee ASADA ANNUAL REPORT 2012:13THERAPEUTIC APPROVALS FOR PROHIBITED SUBSTANCESASDMAC operates as the Australian Therapeutic Use Exemption Committee, providing approval for therapeutic useof prohibited substances to certain athletes if:> their national sporting organisation’s (NSO) anti-doping policy allows for, or permits, the athlete to seek approvalto use a medication prohibited in sport for a legitimate therapeutic purpose> there is no alternative and permitted therapeutic substance available that could be prescribed to treat theathlete’s medical condition> there is no evidence that the athlete will gain a performance enhancement effect by using the substance.MEMBERSProfessor Ken Fitch AM — ChairMBBS, MD, DSc (Hons), FRACGP, FACRM, FACSM, FASMF, FACSPProfessor Ken Fitch is an Adjunct Professor at the School of Sports Science, Exercise and Health, Faculty of LifeSciences, University of Western Australia; a Member of the International Olympic Committee’s (IOC) MedicalCommission; Chairman of the IOC Games Group; Chairman, IOC’s Therapeutic Use Exemption Committee;Chairman of the Therapeutic Use Committee of the Oceania Regional Anti-Doping Organisation; Chairman ofthe Therapeutic Use Committee of the Commonwealth Games Federation; a Member of the Australian DopingResearch Panel; a Member of the International Cricket Council (ICC) Anti-Doping Panel; a Member of theTherapeutic Use Committee of the Professional Golfers Association European Tour; the Emeritus ConsultantPhysician for Sports Medicine at the Department of Orthopaedic Surgery, Royal Perth Hospital; and a Memberof the Medical Commission of the Australian Olympic Committee.Dr Susan White — MemberMBBS (Hons), FACSP, FASMFDr Susan White is a Sports Physician at the Olympic Park Sports Medicine Centre in Melbourne; a Member ofthe Medical Commission of the Australian Olympic Committee; was the Deputy Medical Director for the AustralianOlympic Team in London 2012; Chief Medical Officer of Swimming Australia; is on the Editorial Boards of theClinical Journal of Sports Medicine and the British Journal of Sports Medicine; is a Member of the Anti-DopingPanel of Cricket Australia; the Australian Football League Tribunal (Anti-Doping); the WADA TUE Expert Group;Team Physician for the Australian Swim Team; and Team Physician Melbourne Vixens Netball Team.Dr Peter Harcourt OAM —MemberMBBS, FACSP, FASMF, Dip ObsDr Peter Harcourt is the Sports Physician Chair of the Australian Commonwealth Games Association; MedicalCoordinator for the Victorian Institute of Sport; is a Director of Sports Medicine Australia; is the Clinical Convenorfor the Health Services Group (WorkSafe and Transport Accident Commission) Victoria; is the Chief Medical Officerfor Basketball Australia; the Medical Director of the Australian Football League; the Anti-Doping Medical Officerof Cricket Australia; Chair of the International Cricket Council Medical Committee and Therapeutic Use ExemptionCommittee; Chairman of the Federation Internationale de Basketball Medical Council and Therapeutic UseExemption Committee; Member of the Commonwealth Games Federation Medical Commission; Team Physicianfor the Melbourne Victory Football Club; and Senior Fellow of the Faculty of Law at the University of Melbourne.139
Page 1:
AUSTRALIAN SPORTS ANTI-DOPING AUTHO
Page 4 and 5:
Australian Sports Anti-Doping Autho
Page 6 and 7:
ABOUT THIS REPORTThis report provid
Page 8 and 9:
Long-term storage facility 46Accred
Page 10 and 11:
LIST OF FIGURESFigure 1: Australia
Page 12 and 13:
MESSAGE FROM THE CEOOur purpose is
Page 14 and 15:
DETERRENCE, DETECTION AND ENFORCEME
Page 16 and 17:
We also continued to support the ac
Page 19 and 20:
Organisational overview ASADA ANNUA
Page 21 and 22:
Page 23 and 24:
Page 25:
Page 28 and 29:
This report on performance addresse
Page 30 and 31:
Quantitative deliverables 2012-13 t
Page 32 and 33:
BUILDING AWARENESSASADA’s educati
Page 34 and 35:
Prohibited ListEach year ASADA unde
Page 36 and 37:
EducationASADA continues to place g
Page 38 and 39:
In 2012-13, we continued to encoura
Page 40 and 41:
CASE STUDYSwimming AustraliaIn 2012
Page 42 and 43:
In 2012-13 we continued to maintain
Page 44 and 45:
Institute of National Anti-Doping O
Page 46 and 47:
Additionally, ASADA hosted a visit
Page 48 and 49:
Table 7: ANTI-DOPING TESTS CONDUCTE
Page 50 and 51:
INVESTIGATIONS AND INTELLIGENCE COU
Page 52 and 53:
From the outset of Operation Cobia,
Page 54 and 55:
Table 10: BREAKDOWN OF ANTI-DOPING
Page 57 and 58:
Management and accountability ASADA
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69:
Page 72 and 73:
SUMMARY OF FINANCIAL PERFORMANCE 20
Page 74 and 75:
Table 12: TRENDS IN CONSULTANCIESCo
Page 77:
Financial statements ASADA ANNUAL R
Page 81:
Page 85:
Page 89 and 90: Financial statements ASADA ANNUAL R
Page 95: Financial statements ASADA ANNUAL R
Page 99: Financial statements ASADA ANNUAL R
Page 102 and 103: 100
Page 104 and 105: 102
Page 106 and 107: 104
Page 108 and 109: 106
Page 110 and 111: 108
Page 112 and 113: 110
Page 114 and 115: 112
Page 116 and 117: 114
Page 118 and 119: 116
Page 120 and 121: 118
Page 122 and 123: 120
Page 124 and 125: 122
Page 126 and 127: 124
Page 128 and 129: 126
Page 130 and 131: OVERVIEWThe Australian Sports Anti-
Page 132 and 133: 130
Page 134 and 135: OVERVIEWThe Anti-Doping Rule Violat
Page 136 and 137: RESOURCESThe ADRVP is funded from t
Page 138 and 139: 136
Page 142 and 143: Dr Hugh Hazard — MemberMBBS, Grad
Page 144 and 145: RESOURCESASDMAC is funded from the
Page 146 and 147: SPORT Approved Closed Pending Rejec
Page 148 and 149: 146
Page 150 and 151: Appendix A: DOPING CONTROL STATISTI
Page 152 and 153: Sport Substance name Substance clas
Page 154 and 155: Appendix D: POWERS OF THE MINISTER
Page 156 and 157: Appendix F: STAFFING STATISTICS AT
Page 158 and 159: Appendix G: WORKPLACE HEALTH AND SA
Page 160 and 161: Appendix I: ECOLOGICALLY SUSTAINABL
Page 162 and 163: Appendix K: EXPENSES FOR OUTCOME 1T
Page 164 and 165: 162
Page 166 and 167: LIST OF ABBREVIATIONSABP Athlete Bi
Page 168 and 169: GLOSSARYAdverse analytical findingA
Page 170 and 171: TestingThe parts of the doping cont
Page 172 and 173: 170
Page 174 and 175: COMPLIANCE INDEXDescription Require
Page 176 and 177: Description Requirement PageManagem
Page 178 and 179: ALPHABETICAL INDEXAabbreviations 16
Page 180 and 181: development 66learning 66management
Page 182 and 183: UUnited Nations Educational, Scient
Page 184: AUSTRALIAN SPORTS ANTI-DOPING AUTHO
show all

PDF - 4.73MB - Australian Sports Anti-Doping Authority

Create successful ePaper yourself

Delete template?

Save as template?